BRIEF published on 08/05/2024 at 07:05, 2 years ago Relief Therapeutics obtient jusqu'à 11 millions de dollars grâce aux ventes de redevances Développement Clinique Financement Non Dilutif Approbation De La FDA Thérapeutique De Soulagement Ventes De Redevances
PRESS RELEASE published on 08/05/2024 at 07:00, 2 years ago Relief Therapeutics Secures up to $11 Million from Royalty Sales Relief Therapeutics secures $11 million from royalty sales for RLF-TD011 clinical development and pipeline advancement. Funding from SWK Holdings Corporation to support rare disease treatment options SWK Holdings Corporation Clinical Development Relief Therapeutics Rare Diseases Royalty Sales
BRIEF published on 06/27/2024 at 12:50, 2 years 1 month ago Relief Therapeutics Holding SA publie les résultats de son assemblée générale annuelle Actionnaires Conseil D'administration États Financiers Résultats De L'AGA Thérapeutique De Soulagement
BRIEF published on 06/27/2024 at 12:50, 2 years 1 month ago Relief Therapeutics Holding SA Reports Results of Annual General Meeting Board Of Directors Shareholders Financial Statements Relief Therapeutics AGM Results
PRESS RELEASE published on 06/27/2024 at 12:45, 2 years 1 month ago RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting RELIEF THERAPEUTICS Holding SA announces the results of its Annual General Meeting of Shareholders in Geneva. Details on approved resolutions and election outcomes Annual General Meeting Shareholders Resolutions RELIEF THERAPEUTICS Holding SA Geneva
BRIEF published on 06/03/2024 at 07:05, 2 years 2 months ago Relief Therapeutics Announces Executive Changes Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
BRIEF published on 06/03/2024 at 07:05, 2 years 2 months ago Relief Therapeutics annonce des changements à la direction Conseil D'administration Biopharmaceutique Changements De Direction Thérapeutique De Soulagement La Haute Direction
PRESS RELEASE published on 06/03/2024 at 07:00, 2 years 2 months ago Relief Therapeutics Announces Executive Changes Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF published on 05/30/2024 at 07:05, 2 years 2 months ago Relief Therapeutics annonce l'avis de convocation à l'assemblée générale annuelle des actionnaires Biopharmaceutique AGA 2024 Thérapeutique De Soulagement Rencontre D'actionnaires Genève
BRIEF published on 05/30/2024 at 07:05, 2 years 2 months ago Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
Published on 08/06/2026 at 01:40, 1 hour 11 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 3 hours 11 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 3 hours 41 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 3 hours 50 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/05/2026 at 23:00, 3 hours 51 minutes ago Pentagon I Capital Corp. Announces Filing of Filing Statement with Respect to Its Qualifying Transaction
Published on 08/05/2026 at 23:23, 3 hours 28 minutes ago EQS-Adhoc: Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Published on 08/05/2026 at 23:04, 3 hours 47 minutes ago AUTODOC to publish H1 2026 report and host a conference call on Q2 results on 13 August 2026
Published on 08/05/2026 at 19:14, 7 hours 37 minutes ago 2CRSi informe le marché sur la gouvernance de la société AETHER Infrastructures et l’avancement du projet AETHER auquel 2CRSi participe comme membre du consortium
Published on 08/05/2026 at 19:14, 7 hours 37 minutes ago 2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:00, 8 hours 51 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
Published on 08/05/2026 at 18:00, 8 hours 51 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 9 hours 1 minute ago Mersen : nombre d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 17:49, 9 hours 1 minute ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 9 hours 6 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
